Early research (Phase 1)UnknownNCT05549557What this trial is testingIMM40H Phase I Dose Escalation and ExpansionWho this might be right forTumor ImmuneOnco Biopharmaceuticals (Shanghai) Inc. 16
Testing effectiveness (Phase 2)Study completedNCT04333914What this trial is testingProspective Study in Patients With Advanced or Metastatic Cancer and SARS-CoV-2 InfectionWho this might be right forSARS-CoV-2 (COVID-19) InfectionAdvanced or Metastatic Hematological or Solid Tumor Centre Leon Berard 19
Testing effectiveness (Phase 2)Ended earlyNCT02465528What this trial is testingCeritinib Rare Indications Study in ALK+ TumorsWho this might be right forTumors With Aberrations in ALKAnaplastic Large Cell LymphomaInflammatory Myofibroblastic Tumor+1 more Novartis Pharmaceuticals 22
Testing effectiveness (Phase 2)Study completedNCT00823524What this trial is testingDonor Natural Killer Cells After Donor Stem Cell Transplant in Treating Patients With Advanced CancerWho this might be right forBrain and Central Nervous System TumorsChronic Myeloproliferative DisordersLeukemia+6 more Asan Medical Center 47
Large-scale testing (Phase 3)Study completedNCT00003687What this trial is testingTreatment for Chronic Pain in Patients With Advanced CancerWho this might be right forChronic Myeloproliferative DisordersLeukemiaLymphoma+6 more NCIC Clinical Trials Group 87
Early research (Phase 1)Study completedNCT00025415What this trial is testingImatinib Mesylate in Treating Patients With Advanced Cancer and Liver DysfunctionWho this might be right forAccelerated Phase Chronic Myelogenous LeukemiaAcute Undifferentiated LeukemiaAIDS-related Peripheral/Systemic Lymphoma+78 more National Cancer Institute (NCI) 60
Early research (Phase 1)Looking for participantsNCT05488548What this trial is testingDual BET and CBP/p300 Inhibitor in Patients With Targeted Advanced Solid Tumors and Hematological MalignanciesWho this might be right forCastrate Resistant Prostate CancerNUT CarcinomaChronic Myelomonocytic Leukemia+1 more Epigenetix, Inc. 75
Not applicableUnknownNCT04327583What this trial is testingImpact of the Coordinated Intervention of the Healthcare Facilities Pharmacist and the Dispensary Pharmacist on the Care Pathway for Cancer Patients Treated With Oral TherapyWho this might be right forAdvanced or Metastatic Solid TumorRelapsed Hematologic Malignancy Institut Cancerologie de l'Ouest 396
Early research (Phase 1)Looking for participantsNCT03816345What this trial is testingTesting an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVOWho this might be right forAutoimmune DiseaseCrohn DiseaseDermatomyositis+11 more National Cancer Institute (NCI) 300
Early research (Phase 1)Looking for participantsNCT06225856What this trial is testingAn Open-Label, Multicenter, Phase I Study to Evaluate the Safety, Pharmacokinetics and Preliminary Efficacy of YY201 in Patients With Advanced Solid Tumors and Hematological MalignanciesWho this might be right forAdvanced Solid TumorHematological Malignancy Shanghai Yuyao Biotech Co., Ltd. 96
Early research (Phase 1)UnknownNCT04854681What this trial is testingPhase 1 Trial of the TQB2928 Injection in Patients With Advanced CancersWho this might be right forAdvanced Solid Tumors and Hematological Malignancies Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 20
Early research (Phase 1)Study completedNCT01725555What this trial is testingAssess the Effect of Food on the Bioavailability of the IGF-1R Inhibitor AXL1717 in Patients With Advanced Malignant TumorsWho this might be right forSolid TumorsHematological Malignancies Axelar AB 13
Testing effectiveness (Phase 2)Active Not RecruitingNCT04439253What this trial is testingTesting Crizotinib as a Potential Targeted Treatment in Cancers With ROS1 Genetic Changes (MATCH-Subprotocol G)Who this might be right forAdvanced LymphomaAdvanced Malignant Solid NeoplasmHematopoietic and Lymphoid Cell Neoplasm+3 more National Cancer Institute (NCI) 4
Testing effectiveness (Phase 2)Active Not RecruitingNCT04439318What this trial is testingTesting Trametinib as a Potential Targeted Treatment in Cancers With NF1 Genetic Changes (MATCH-Subprotocol S1)Who this might be right forAdvanced LymphomaAdvanced Malignant Solid NeoplasmHematopoietic and Lymphoid Cell Neoplasm+3 more National Cancer Institute (NCI) 50
Early research (Phase 1)Study completedNCT00003082What this trial is testingMonoclonal Antibody Therapy in Treating Patients With Advanced CancerWho this might be right forChronic Myeloproliferative DisordersLeukemiaLymphoma+4 more University of Arizona 27
Early research (Phase 1)Active Not RecruitingNCT05104775What this trial is testingGNC-035, a Tetra-specific Antibody, in Participants With Relapsed/Refractory Hematologic MalignancyWho this might be right forHematologic Malignancies Sichuan Baili Pharmaceutical Co., Ltd. 33
Very early researchUnknownNCT05707325What this trial is testingSafety, Tolerability and Preliminary Efficacy of Engineered Red Blood Cell in Patients With Advanced MalignanciesWho this might be right forCancerSolid TumorHematologic Malignancy Westlake Therapeutics 30
Large-scale testing (Phase 3)Study completedNCT00538850What this trial is testingFentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer PainWho this might be right forCancer INSYS Therapeutics Inc 130
Early research (Phase 1)Study completedNCT00002980What this trial is testingDecitabine in Treating Patients With Melanoma or Other Advanced CancerWho this might be right forChronic Myeloproliferative DisordersLeukemiaLymphoma+4 more California Cancer Consortium
Early research (Phase 1)Ended earlyNCT04272203What this trial is testingDetermine Safety, Tolerability, Pharmacokinetics, and Recommended Phase 2 Dose (RP2D) of Intravenous ABBV-184 in Adult Participants With Previously Treated CancersWho this might be right forAcute Myeloid Leukemia (AML)Non Small Cell Lung CancerCancer AbbVie 14